Primary hepatocytes as a model to analyze species-specific toxicity and drug metabolism

Bibliography

• DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. J Health Econ 2003;22:151-85
   PubMed Web of Science ®Google Scholar
• Rawlins MD. Cutting the cost of drug development? Nat Rev Drug Discov 2004;3:360-4
   PubMed Web of Science ®Google Scholar
• Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 2004;3:711-6
   PubMed Web of Science ®Google Scholar
• Olson H, Betton G, Robinson D, et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol 2000;32:56-67
   PubMed Web of Science ®Google Scholar
• Olson H, Betton G, Stritar J, et al. The predictivity of the toxicity of pharmaceuticals in humans from animal data - an interim assessment. Toxicol Lett 1998;102-103:535-8
   PubMed Web of Science ®Google Scholar
• Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov 2005;4:489-99
   PubMed Web of Science ®Google Scholar
• Guengerich FP, MacDonald JS. Applying mechanisms of chemical toxicity to predict drug safety. Chem Res Toxicol 2007;20:344-69
   PubMed Web of Science ®Google Scholar
• Fung M, Thornton A, Mybeck K, et al. Evaluation of the characteristics of safety withdrawal of prescription drugs from worldwide pharmaceutical markets-1960 to 1999. Drug Inf J 2001;35:293-317
   Web of Science ®Google Scholar
• Andrade RJ, Camargo R, Lucena MI, et al. Causality assessment in drug-induced hepatotoxicity. Expert Opin Drug Saf 2004;3:329-44
   PubMedGoogle Scholar
• Kaplowitz N. Drug-induced liver disorders: implications for drug development and regulation. Drug Saf 2001;24:483-90
   PubMed Web of Science ®Google Scholar
• Lewis JH. Drug-induced liver disease. Curr Opin Gastroenterol 2002;18:307-13
   PubMed Web of Science ®Google Scholar
• Russo MW, Galanko JA, Shrestha R, et al. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl 2004;10:1018-23
   PubMed Web of Science ®Google Scholar
• Lee WM. Drug-induced hepatotoxicity. N Engl J Med 2003;349:474-85
   PubMed Web of Science ®Google Scholar
• Boelsterli UA. Disease-related determinants of susceptibility to drug-induced idiosyncratic hepatotoxicity. Curr Opin Drug Discov Devel 2003;6:81-91
   PubMed Web of Science ®Google Scholar
• Jaeschke H, Gores GJ, Cederbaum AI, et al. Mechanisms of hepatotoxicity. Toxicol Sci 2002;65:166-76
   PubMed Web of Science ®Google Scholar
• Xu JJ, Diaz D, O'Brien PJ. Applications of cytotoxicity assays and pre-lethal mechanistic assays for assessment of human hepatotoxicity potential. Chem Biol Interact 2004;150:115-28
   PubMed Web of Science ®Google Scholar
• Kaplowitz N. Mechanisms of liver cell injury. J Hepatol 2000;32:39-47
   PubMed Web of Science ®Google Scholar
• Kaplowitz N. Drug-induced liver injury. Clin Infect Dis 2004;38(Suppl 2):S44-8
   PubMed Web of Science ®Google Scholar
• Uetrecht J. Idiosyncratic drug reactions: past, present, and future. Chem Res Toxicol 2008;21:84-92
   PubMed Web of Science ®Google Scholar
• Shaw PJ, Hopfensperger MJ, Ganey PE, et al. Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha. Toxicol Sci 2007;100:259-66
   PubMed Web of Science ®Google Scholar
• Ganey PE, Luyendyk JP, Maddox JF, Roth RA. Adverse hepatic drug reactions: inflammatory episodes as consequence and contributor. Chem Biol Interact 2004;150:35-51
   PubMed Web of Science ®Google Scholar
• Boelsterli UA. Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity. Toxicol Appl Pharmacol 2003;192:307-22
   PubMed Web of Science ®Google Scholar
• Daly AK, Aithal GP, Leathart JB, et al. Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes. Gastroenterology 2007;132:272-81
   PubMed Web of Science ®Google Scholar
• Tang W. The metabolism of diclofenac – enzymology and toxicology perspectives. Curr Drug Metab 2003;4:319-29
   PubMed Web of Science ®Google Scholar
• Yan Z, Li J, Huebert N, et al. Detection of a novel reactive metabolite of diclofenac: evidence for CYP2C9-mediated bioactivation via arene oxides. Drug Metab Dispos 2005;33:706-13
   PubMed Web of Science ®Google Scholar
• Goldkind L, Laine L. A systematic review of NSAIDs withdrawn from the market due to hepatotoxicity: lessons learned from the bromfenac experience. Pharmacoepidemiol Drug Saf 2006;15:213-20
   PubMed Web of Science ®Google Scholar
• Fontana RJ, McCashland TM, Benner KG, et al. Acute liver failure associated with prolonged use of bromfenac leading to liver transplantation. The Acute Liver Failure Study Group. Liver Transpl Surg 1999;5:480-4
   PubMedGoogle Scholar
• Otto M, Hansen SH, Dalgaard L, et al. Development of an in vitro assay for the investigation of metabolism-induced drug hepatotoxicity. Cell Biol Toxicol 2008;24:87-99
   PubMed Web of Science ®Google Scholar
• Tugwood JD, Montague CT. Biology and toxicology of PPARgamma ligands. Hum Exp Toxicol 2002;21:429-37
   PubMed Web of Science ®Google Scholar
• Smith MT. Mechanisms of troglitazone hepatotoxicity. Chem Res Toxicol 2003;16:679-87
   PubMed Web of Science ®Google Scholar
• He K, Talaat RE, Pool WF, et al. Metabolic activation of troglitazone: identification of a reactive metabolite and mechanisms involved. Drug Metab Dispos 2004;32:639-46
   PubMed Web of Science ®Google Scholar
• Lee WM, Senior JR. Recognizing drug-induced liver injury: current problems, possible solutions. Toxicol Pathol 2005;33:155-64
   PubMed Web of Science ®Google Scholar
• Hinson JA, Reid AB, McCullough SS, et al. Acetaminophen-induced hepatotoxicity: role of metabolic activation, reactive oxygen/nitrogen species, and mitochondrial permeability transition. Drug Metab Rev 2004;36:805-22
   PubMed Web of Science ®Google Scholar
• James LP, Mayeux PR, Hinson JA. Acetaminophen-induced hepatotoxicity. Drug Metab Dispos 2003;31:1499-506
   PubMed Web of Science ®Google Scholar
• Shen C, Zhang G, Qiu H, et al. Acetaminophen-induced hepatotoxicity of gel entrapped rat hepatocytes in hollow fibers. Chem Biol Interact 2006;162:53-61
   PubMed Web of Science ®Google Scholar
• Farkas D, Tannenbaum SR. Characterization of chemically induced hepatotoxicity in collagen sandwiches of rat hepatocytes. Toxicol Sci 2005;85:927-34
   PubMed Web of Science ®Google Scholar
• Jemnitz K, Veres Z, Monostory K, et al. Interspecies differences in acetaminophen sensitivity of human, rat, and mouse primary hepatocytes. Toxicol In Vitro 2008;22:961-7
   PubMed Web of Science ®Google Scholar
• Smolarek TA, Higgins CV, Amacher DE. Metabolism and cytotoxicity of acetaminophen in hepatocyte cultures from rat, rabbit, dog, and monkey. Drug Metab Dispos 1990;18:659-63
   PubMed Web of Science ®Google Scholar
• de Longueville F, Atienzar FA, Marcq L, et al. Use of a low-density microarray for studying gene expression patterns induced by hepatotoxicants on primary cultures of rat hepatocytes. Toxicol Sci 2003;75:378-92
   PubMed Web of Science ®Google Scholar
• Brandon EF, Raap CD, Meijerman I, et al. An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicol Appl Pharmacol 2003;189:233-46
   PubMed Web of Science ®Google Scholar
• Scholz G, Pohl I, Genschow E, et al. Embryotoxicity screening using embryonic stem cells in vitro: correlation to in vivo teratogenicity. Cells Tissues Organs 1999;165:203-11
   PubMed Web of Science ®Google Scholar
• De Smet K, Loyer P, Gilot D, et al. Effects of epidermal growth factor on CYP inducibility by xenobiotics, DNA replication, and caspase activations in collagen I gel sandwich cultures of rat hepatocytes. Biochem Pharmacol 2001;61:1293-303
   PubMed Web of Science ®Google Scholar
• Ching KZ, Tenney KA, Chen J, et al. Suppression of constitutive cytochrome P450 gene expression by epidermal growth factor receptor ligands in cultured rat hepatocytes. Drug Metab Dispos 1996;24:542-6
   PubMed Web of Science ®Google Scholar
• Gordon EM, Douglas MC, Jablonski P, et al. Gastroduodenal hormones and bile-secretion studies in the isolated perfused pig liver. Surgery 1972;72:708-21
   PubMed Web of Science ®Google Scholar
• Vickers AEM. Liver slices: an in vitro tool to predict drug biotransformation and to support risk assessment. In Vitro Toxicol 1997;10:71-80
   Google Scholar
• Vickers AE, Fisher RL. Organ slices for the evaluation of human drug toxicity. Chem Biol Interact 2004;150:87-96
   PubMed Web of Science ®Google Scholar
• Boess F, Kamber M, Romer S, et al. Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems. Toxicol Sci 2003;73:386-402
   PubMed Web of Science ®Google Scholar
• Knasmuller S, Mersch-Sundermann V, Kevekordes S, et al. Use of human-derived liver cell lines for the detection of environmental and dietary genotoxicants; current state of knowledge. Toxicology 2004;198:315-28
   PubMed Web of Science ®Google Scholar
• Hewitt NJ, Hewitt P. Phase I and II enzyme characterization of two sources of HepG2 cell lines. Xenobiotica 2004;34:243-56
   PubMed Web of Science ®Google Scholar
• Parent R, Marion MJ, Furio L, et al. Origin and characterization of a human bipotent liver progenitor cell line. Gastroenterology 2004;126:1147-56
   PubMed Web of Science ®Google Scholar
• Gripon P, Rumin S, Urban S, et al. Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci USA 2002;99:15655-60
   PubMed Web of Science ®Google Scholar
• Aninat C, Piton A, Glaise D, et al. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells. Drug Metab Dispos 2006;34:75-83
   PubMed Web of Science ®Google Scholar
• Lu HF, Chua KN, Zhang PC, et al. Three-dimensional co-culture of rat hepatocyte spheroids and NIH/3T3 fibroblasts enhances hepatocyte functional maintenance. Acta Biomater 2005;1:399-410
   PubMed Web of Science ®Google Scholar
• Mertsching H, Walles T, Hofmann M, et al. Engineering of a vascularized scaffold for artificial tissue and organ generation. Biomaterials 2005;26:6610-7
   PubMed Web of Science ®Google Scholar
• Linke K, Schanz J, Hansmann J, et al. Engineered liver-like tissue on a capillarized matrix for applied research. Tissue Eng 2007;13:2699-707
   PubMedGoogle Scholar
• Hwa AJ, Fry RC, Sivaraman A, et al. Rat liver sinusoidal endothelial cells survive without exogenous VEGF in 3D perfused co-cultures with hepatocytes. FASEB J 2007;21:2564-79
   PubMed Web of Science ®Google Scholar
• Milosevic N, Schawalder H, Maier P. Kupffer cell-mediated differential down-regulation of cytochrome P450 metabolism in rat hepatocytes. Eur J Pharmacol 1999;368:75-87
   PubMed Web of Science ®Google Scholar
• Zinchenko YS, Schrum LW, Clemens M, Coger RN. Hepatocyte and kupffer cells co-cultured on micropatterned surfaces to optimize hepatocyte function. Tissue Eng 2006;12:751-61
   PubMedGoogle Scholar
• Gebhardt R, Hengstler JG, Muller D, et al. New hepatocyte in vitro systems for drug metabolism: metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures. Drug Metab Rev 2003;35:145-213
   PubMed Web of Science ®Google Scholar
• Elaut G, Papeleu P, Vinken M, et al. Hepatocytes in suspension. Methods Mol Biol 2006;320:255-63
   PubMedGoogle Scholar
• Hewitt NJ, Lecluyse EL, Ferguson SS. Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro-in vivo correlations. Xenobiotica 2007;37:1196-224
   PubMed Web of Science ®Google Scholar
• Dunn JC, Tompkins RG, Yarmush ML. Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration. Biotechnol Prog 1991;7:237-45
   PubMed Web of Science ®Google Scholar
• Bi Y-a, Kazolias D, Duignan DB. Use of cryopreserved human hepatocytes in sandwich culture to measure hepatobiliary transport. Drug Metab Dispos 2006;34:1658-65
   PubMed Web of Science ®Google Scholar
• Tuschl G, Hrach J, Hewitt P, et al. Application of short and long-term hepatocyte cultures to predict toxicities. In: Sahu SC, editor, Hepatotoxicity: from genomics to in vitro and in vivo models. Chichester, UK: John Wiley & Sons; 2007
   Google Scholar
• Tuschl G, Mueller SO. Effects of cell culture conditions on primary rat hepatocytes – cell morphology and differential gene expression. Toxicology 2006;218:205-15
   PubMed Web of Science ®Google Scholar
• LeCluyse EL, Alexandre E, Hamilton GA, et al. Isolation and culture of primary human hepatocytes. Methods Mol Biol 2005;290:207-29
   PubMedGoogle Scholar
• Li AP. Human hepatocytes: isolation, cryopreservation and applications in drug development. Chem Biol Interact 2007;168:16-29
   PubMed Web of Science ®Google Scholar
• Stevenson DJ, Morgan C, McLellan LI, et al. Reduced glutathione levels and expression of the enzymes of glutathione synthesis in cryopreserved hepatocyte monolayer cultures. Toxicol Vitro 2007;21:527-32
   PubMed Web of Science ®Google Scholar
• Taylor DL. Past, present, and future of high content screening and the field of cellomics. Methods Mol Biol 2007;356:3-18
   PubMedGoogle Scholar
• Giuliano KA, Haskins JR, Taylor DL. Advances in high content screening for drug discovery. Assay Drug Dev Technol 2003;1:565-77
   PubMed Web of Science ®Google Scholar
• Giuliano KA, Cheung WS, Curran DP, et al. Systems cell biology knowledge created from high content screening. Assay Drug Dev Technol 2005;3:501-14
   PubMed Web of Science ®Google Scholar
• Taylor DL, Woo ES, Giuliano KA. Real-time molecular and cellular analysis: the new frontier of drug discovery. Curr Opin Biotechnol 2001;12:75-81
   PubMed Web of Science ®Google Scholar
• Abraham VC, Taylor DL, Haskins JR. High content screening applied to large-scale cell biology. Trends Biotechnol 2004;22:15-22
   PubMed Web of Science ®Google Scholar
• O'Brien PJ, Irwin W, Diaz D, et al. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch Toxicol 2006;80:580-604
   PubMed Web of Science ®Google Scholar
• Kostrubsky VE, Strom SC, Hanson J, et al. Evaluation of hepatotoxic potential of drugs by inhibition of bile-acid transport in cultured primary human hepatocytes and intact rats. Toxicol Sci 2003;76:220-8
   PubMed Web of Science ®Google Scholar
• Richert L, Tuschl G, Abadie C, et al. Species differences in the response of liver drug metabolizing enzymes to EMD 392949 in vivo and in vitro. Drug Metab Dispos 2008;36:702-14
   PubMed Web of Science ®Google Scholar
• Valet G. Cytomics as a new potential for drug discovery. Drug Discov Today 2006;11:785-91
   PubMed Web of Science ®Google Scholar
• Ganter B, Snyder RD, Halbert DN, et al. Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix database. Pharmacogenomics 2006;7:1025-44
   PubMed Web of Science ®Google Scholar
• Mattes WB, Pettit SD, Sansone SA, et al. Database development in toxicogenomics: issues and efforts. Environ Health Perspect 2004;112:495-505
   PubMed Web of Science ®Google Scholar
• Ellinger-Ziegelbauer H, Stuart B, Wahle B, et al. Characteristic expression profiles induced by genotoxic carcinogens in rat liver. Toxicol Sci 2004;77:19-34
   PubMed Web of Science ®Google Scholar
• Fella K, Glückmann M, Hellmann J, et al. Use of two-dimensional gel electrophoresis in predictive toxicology: Identification of potential early protein biomarkers in chemically induced hepatocarcinogenesis. Proteomics 2005;5:1914-27
   PubMed Web of Science ®Google Scholar
• Heinloth AN, Irwin RD, Boorman GA, et al. Gene expression profiling of rat livers reveals indicators of potential adverse effects. Toxicol Sci 2004;80:193-202
   PubMed Web of Science ®Google Scholar
• Waring JF, Ciurlionis R, Jolly RA, et al. Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol Lett 2001;120:359-68
   PubMed Web of Science ®Google Scholar
• Witzmann FA, Clack JW, Geiss K, et al. Proteomic evaluation of cell preparation methods in primary hepatocyte cell culture. Electrophoresis 2002;23:2223-32
   PubMed Web of Science ®Google Scholar
• Lim PLK, Liu J, Go ML, et al. The mitochondrial Superoxide/Thioredoxin-2/Ask1 signaling pathway is critically involved in troglitazone-induced cell injury to human hepatocytes. Toxicol Sci 2008;101:341-9
   PubMed Web of Science ®Google Scholar
• Waring JF, Liguori MJ, Luyendyk JP, et al. Microarray analysis of lipopolysaccharide potentiation of trovafloxacin-induced liver injury in rats suggests a role for proinflammatory chemokines and neutrophils. J Pharmacol Exp Ther 2006;316:1080-7
   PubMed Web of Science ®Google Scholar
• Liguori MJ, Anderson MG, Bukofzer S, et al. Microarray analysis in human hepatocytes suggests a mechanism for hepatotoxicity induced by trovafloxacin. Hepatology 2005;41:177-86
   PubMed Web of Science ®Google Scholar
• Hewitt NJ, Lechon MJG, Houston JB, et al. Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metabol Rev 2007;39:159-234
   PubMed Web of Science ®Google Scholar
• Dixit R, Boelsterli UA. Healthy animals and animal models of human disease(s) in safety assessment of human pharmaceuticals, including therapeutic antibodies. Drug Discov Today 2007;12:336-42
   PubMed Web of Science ®Google Scholar
• Shankar K, Vaidya VS, Wang T, et al. Streptozotocin-induced diabetic mice are resistant to lethal effects of thioacetamide hepatotoxicity. Toxicol Appl Pharmacol 2003;188:122-34
   PubMed Web of Science ®Google Scholar
• Wang T, Fontenot RD, Soni MG, et al. Enhanced hepatotoxicity and toxic outcome of thioacetamide in streptozotocin-induced diabetic rats. Toxicol Appl Pharmacol 2000;166:92-100
   PubMed Web of Science ®Google Scholar
• Tukov FF, Maddox JF, Amacher DE, et al. Modeling inflammation-drug interactions in vitro: a rat Kupffer cell-hepatocyte coculture system. Toxicol Vitro 2006;20:1488-99
   PubMed Web of Science ®Google Scholar
• Mueller SO, Tuschl G, Kling M. Alternatives in pharmaceutical toxicology: global and focussed approaches – two case studies. ALTEX 2007;24:117-24
   PubMed Web of Science ®Google Scholar
• Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976;13:29-83
   PubMedGoogle Scholar
• Guillouzo A. Liver cell models in in vitro toxicology. Environ Health Perspect 1998;106:511-32
   PubMed Web of Science ®Google Scholar
• Groneberg DA, Grosse-Siestrup C, Fischer A. In vitro models to study hepatotoxicity. Toxicol Pathol 2002;30:394-9
   PubMed Web of Science ®Google Scholar
• Farkas D, Tannenbaum SR. In vitro methods to study chemically-induced hepatotoxicity: a literature review. Curr Drug Metab 2005;6:111-25
   PubMed Web of Science ®Google Scholar
• Sivaraman A, Leach JK, Townsend S, et al. A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction. Curr Drug Metab 2005;6:569-91
   PubMed Web of Science ®Google Scholar